BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  How Regeneron Is Benefiting From Continued Sanofi Investments

  October 24, 2014

   · 

  1 min read
• 

  Shire Stands To Grab $1.6B From AbbVie In Third Largest Breakup Fee In History

  October 24, 2014

   · 

  2 min read
• 

  Bio NC

  BioSpace’s Favorite FDA Tricks Or Treats

  October 24, 2014

   · 

  8 min read
• 

  Policy

  Tug-Of-War Over Revlimid Patent Continues Between Celgene, Natco Pharma Limited

  October 24, 2014

   · 

  1 min read
• Business

  Stellar Biotechnologies, Inc. And Biovest International, Inc. Sign KLH Supply Agreement For BiovaxID Immunotherapy For Follicular Non-Hodgkin’s Lymphoma

  October 24, 2014

   · 

  6 min read
• Biomax Informatics launches BioXM™ Knowledge Management Environment Version 5.1

  October 24, 2014

   · 

  1 min read
• Drug Development

  ALS ACT, The ALS Association, And The Northeast ALS Consortium Issue Request For Proposals For Phase 2 Clinical Development Of Novel, High-Potential Treatments For ALS

  October 24, 2014

   · 

  3 min read
• Drug Development

  Rhythm Presents Positive Phase 2 Study Results For Relamorelin For Chronic Constipation

  October 24, 2014

   · 

  6 min read
• Drug Development

  Verastem, Inc. Presents New Data On Mesothelioma Programs At The 12th International Mesothelioma Interest Group Meeting

  October 24, 2014

   · 

  9 min read
• ERYtech Pharma: Prospectus Made Available After Obtaining Visa N° 14-566 From The French Financial Markets Authority

  October 24, 2014

   · 

  1 min read